• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

包绕肿瘤簇的血管在钆塞酸二钠增强磁共振成像上促成了肝癌的瘤内异质性。

Vessels encapsulating tumor clusters contribute to the intratumor heterogeneity of HCC on Gd-EOB-DTPA-enhanced MRI.

作者信息

Matsuda Kosuke, Ueno Akihisa, Tsuzaki Junya, Kurebayashi Yutaka, Masugi Yohei, Yamazaki Ken, Tamura Masashi, Abe Yuta, Hasegawa Yasushi, Kitago Minoru, Jinzaki Masahiro, Sakamoto Michiie

机构信息

Department of Pathology, Keio University School of Medicine, Tokyo, Japan.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000593. eCollection 2025 Jan 1.

DOI:10.1097/HC9.0000000000000593
PMID:39670871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11637751/
Abstract

BACKGROUND

Vessels encapsulating tumor clusters (VETC) pattern is tumor vasculature of HCC and is a predictor of prognosis and therapeutic efficacy. Recent radiological studies have demonstrated the predictability of VETC from preoperative images, but the mechanisms of image formation are not elucidated. This study aims to determine the relationship between VETC and intratumor heterogeneity in Gd-EOB-DTPA-enhanced magnetic resonance imaging (EOB-MRI) and to provide its pathological evidence.

METHODS

Radiologists visually classified preoperative arterial- and hepatobiliary-phase EOB-MRI images of 204 surgically resected HCCs into patterns based on heterogeneity and signal intensity; these classifications were validated using texture analysis. Single and multiplex immunohistochemistry for CD34, h-caldesmon, and OATP1B3 were performed to evaluate VETC, arterial vessel density (AVD), and OATP1B3 expression. Recurrence-free survival was assessed using the generalized Wilcoxon test. The contribution of clinicoradiological factors to the prediction of VETC was evaluated by random forest and least absolute shrinkage and selection operator regression.

RESULTS

VETC was frequently found in tumors with arterial-phase heterogeneous hyper-enhancement patterns and in tumors with hepatobiliary-phase heterogeneous hyperintense/isointense patterns (HBP-Hetero). AVD and OATP1B3 expression positively correlated with signal intensity in the arterial and hepatobiliary phases, respectively. Intratumor spatial analysis revealed that AVD and OATP1B3 expression were lower in VETC regions than in tumor regions without VETC. Patients with HBP-Hetero tumors had shorter recurrence-free survival. Machine learning models highlighted the importance of serum PIVKA-II, tumor size, and enhancement pattern of arterial and hepatobiliary phase for VETC prediction.

CONCLUSIONS

VETC is associated with local reductions of both AVD and OATP1B3 expression, likely contributing to heterogeneous enhancement patterns in EOB-MRI. Evaluation of the arterial and hepatobiliary phases of EOB-MRI would enhance the predictability of VETC.

摘要

背景

包裹肿瘤细胞簇的血管(VETC)模式是肝细胞癌的肿瘤血管系统,是预后和治疗效果的预测指标。近期的放射学研究已证实术前影像对VETC具有预测性,但影像形成机制尚未阐明。本研究旨在确定VETC与钆塞酸二钠增强磁共振成像(EOB-MRI)中肿瘤内异质性之间的关系,并提供其病理证据。

方法

放射科医生根据异质性和信号强度,将204例手术切除的肝细胞癌术前动脉期和肝胆期EOB-MRI图像直观地分类为不同模式;这些分类通过纹理分析进行验证。对CD34、h-钙调蛋白和OATP1B3进行单重和多重免疫组织化学检测,以评估VETC、动脉血管密度(AVD)和OATP1B3表达。使用广义Wilcoxon检验评估无复发生存率。通过随机森林以及最小绝对收缩和选择算子回归评估临床放射学因素对VETC预测的贡献。

结果

VETC常见于动脉期异质性高增强模式的肿瘤以及肝胆期异质性高信号/等信号模式(HBP-Hetero)的肿瘤中。AVD和OATP1B3表达分别与动脉期和肝胆期的信号强度呈正相关。肿瘤内空间分析显示,VETC区域的AVD和OATP1B3表达低于无VETC的肿瘤区域。HBP-Hetero肿瘤患者的无复发生存期较短。机器学习模型强调了血清异常凝血酶原、肿瘤大小以及动脉期和肝胆期增强模式对VETC预测的重要性。

结论

VETC与AVD和OATP1B3表达的局部降低有关,可能导致EOB-MRI中的异质性增强模式。评估EOB-MRI的动脉期和肝胆期将提高VETC的预测性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/059954fe44ec/hc9-9-e0593-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/7da6a1cd0d29/hc9-9-e0593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/6caf4cd734f6/hc9-9-e0593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/24ea177e9cce/hc9-9-e0593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/059954fe44ec/hc9-9-e0593-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/7da6a1cd0d29/hc9-9-e0593-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/6caf4cd734f6/hc9-9-e0593-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/24ea177e9cce/hc9-9-e0593-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599c/11637751/059954fe44ec/hc9-9-e0593-g004.jpg

相似文献

1
Vessels encapsulating tumor clusters contribute to the intratumor heterogeneity of HCC on Gd-EOB-DTPA-enhanced MRI.包绕肿瘤簇的血管在钆塞酸二钠增强磁共振成像上促成了肝癌的瘤内异质性。
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000593. eCollection 2025 Jan 1.
2
Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma.基于钆塞酸二钠增强 MRI 的影像学特征预测肝细胞癌患者肿瘤簇包绕血管(VETC)。
Br J Radiol. 2021 Mar 1;94(1119):20200950. doi: 10.1259/bjr.20200950. Epub 2021 Jan 20.
3
Establishment of nomogram prediction model of contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for vessels encapsulating tumor clusters pattern of hepatocellular carcinoma.建立基于超声造影和钆塞酸二钠增强磁共振成像的肝癌肿瘤簇包绕血管模式预测模型。
Biosci Trends. 2024 Jul 9;18(3):277-288. doi: 10.5582/bst.2024.01112. Epub 2024 Jun 12.
4
Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.钆塞酸二钠增强磁共振成像的影像组学用于预测肝细胞癌中肿瘤巢包绕血管(VETC)及患者预后
Eur Radiol. 2022 Feb;32(2):959-970. doi: 10.1007/s00330-021-08250-9. Epub 2021 Sep 4.
5
Prediction of vessels encapsulating tumor clusters pattern and prognosis of hepatocellular carcinoma based on preoperative gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid magnetic resonance imaging.基于术前钆塞酸二钠磁共振成像预测肝细胞癌中包裹肿瘤簇模式及预后。
J Gastrointest Surg. 2024 Apr;28(4):442-450. doi: 10.1016/j.gassur.2024.02.004. Epub 2024 Feb 9.
6
Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular Carcinoma.基于钆塞酸二钠增强磁共振成像的纹理分析用于识别包裹肿瘤簇的血管(VETC)阳性肝细胞癌
J Hepatocell Carcinoma. 2021 May 5;8:349-359. doi: 10.2147/JHC.S293755. eCollection 2021.
7
Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.OATP1B3的表达决定了肝细胞癌中钆塞酸二钠的摄取。
J Gastroenterol. 2009;44(7):793-8. doi: 10.1007/s00535-009-0056-4. Epub 2009 Apr 29.
8
Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.多步骤肝癌发生过程中索拉非尼增强超声成像:与钆塞酸二钠增强MRI的比较
J Gastroenterol. 2014 Jun;49(6):1081-93. doi: 10.1007/s00535-013-0859-1. Epub 2013 Aug 1.
9
Intraindividual comparison of CT and MRI for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma.CT与MRI在预测肝细胞癌中包裹肿瘤簇的血管方面的个体内比较。
Eur Radiol. 2025 Jan;35(1):61-72. doi: 10.1007/s00330-024-10944-9. Epub 2024 Jul 12.
10
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.钆塞酸二钠增强磁共振成像和甲胎蛋白可预测早期肝细胞癌的预后。
Hepatology. 2014 Nov;60(5):1674-85. doi: 10.1002/hep.27093. Epub 2014 Sep 29.

引用本文的文献

1
Biparametric magnetic resonance imaging-based radiomic and deep learning models for predicting Ki-67 risk stratification in hepatocellular carcinoma.基于双参数磁共振成像的放射组学和深度学习模型预测肝细胞癌Ki-67风险分层
World J Hepatol. 2025 Aug 27;17(8):109530. doi: 10.4254/wjh.v17.i8.109530.
2
Spectral computed tomography parameters for predicting vessels encapsulating tumor clusters (VETC) pattern in hepatocellular carcinoma: a pilot study.用于预测肝细胞癌中肿瘤团块包绕血管(VETC)模式的光谱计算机断层扫描参数:一项初步研究。
Quant Imaging Med Surg. 2025 Apr 1;15(4):3285-3297. doi: 10.21037/qims-24-2077. Epub 2025 Mar 28.

本文引用的文献

1
CEMRI-Based Quantification of Intratumoral Heterogeneity for Predicting Aggressive Characteristics of Hepatocellular Carcinoma Using Habitat Analysis: Comparison and Combination of Deep Learning.基于 CEMRI 的肿瘤内异质性定量分析用于基于栖息地分析的肝细胞癌侵袭性特征预测:深度学习的比较与联合。
Acad Radiol. 2024 Jun;31(6):2346-2355. doi: 10.1016/j.acra.2023.11.024. Epub 2023 Dec 6.
2
Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.包裹肿瘤簇的血管:不可切除肝细胞癌肝动脉灌注化疗疗效的新预测指标。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17231-17239. doi: 10.1007/s00432-023-05444-0. Epub 2023 Oct 6.
3
Deep Learning Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma.
用于评估肝细胞癌中包绕肿瘤结节的血管及预后的动态对比增强磁共振成像深度学习影像组学模型
J Magn Reson Imaging. 2024 Jan;59(1):108-119. doi: 10.1002/jmri.28745. Epub 2023 Apr 20.
4
Immunovascular microenvironment in relation to prognostic heterogeneity of WNT/β-catenin-activated hepatocellular carcinoma.与WNT/β-连环蛋白激活的肝细胞癌预后异质性相关的免疫血管微环境
Hepatol Res. 2023 Apr;53(4):344-356. doi: 10.1111/hepr.13869. Epub 2023 Jan 11.
5
Preoperative MRI features for characterization of vessels encapsulating tumor clusters and microvascular invasion in hepatocellular carcinoma.用于表征肝细胞癌中包裹肿瘤结节的血管及微血管侵犯的术前MRI特征
Abdom Radiol (NY). 2023 Feb;48(2):554-566. doi: 10.1007/s00261-022-03740-w. Epub 2022 Nov 16.
6
Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium-Enhanced MRI.基于钆塞酸二钠增强 MRI 术前预测肝细胞癌肿瘤簇包裹血管的列线图模型
J Magn Reson Imaging. 2023 Jun;57(6):1893-1905. doi: 10.1002/jmri.28488. Epub 2022 Oct 19.
7
Texture analysis of contrast-enhanced magnetic resonance imaging predicts microvascular invasion in hepatocellular carcinoma.对比增强磁共振成像的纹理分析可预测肝细胞癌中的微血管侵犯。
Eur J Radiol. 2022 Nov;156:110528. doi: 10.1016/j.ejrad.2022.110528. Epub 2022 Sep 21.
8
Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma.评估钆塞酸增强磁共振成像肝胆期在预测乐伐替尼、阿替利珠单抗联合贝伐单抗对不可切除肝细胞癌治疗效果中的作用。
Cancers (Basel). 2022 Feb 6;14(3):827. doi: 10.3390/cancers14030827.
9
Immunotherapies for hepatocellular carcinoma.肝细胞癌的免疫疗法
Nat Rev Clin Oncol. 2022 Mar;19(3):151-172. doi: 10.1038/s41571-021-00573-2. Epub 2021 Nov 11.
10
Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies.抑制 FGFR 可重新激活肿瘤细胞中的 IFNγ 信号通路,增强仑伐替尼与抗 PD-1 抗体的联合抗肿瘤活性。
Cancer Res. 2022 Jan 15;82(2):292-306. doi: 10.1158/0008-5472.CAN-20-2426. Epub 2021 Nov 9.